Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
- Peter Lynch
What is insider trading>>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Amendment No.__)*
Under the Securities Exchange Act of 1934
Definitive Healthcare Corp.
(Name of Issuer)
Class A common stock, $0.001 par value per share
(Title of Class of Securities)
24477E103
(CUSIP Number)
December 31, 2021
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☐ Rule 13d-1(c)
☒ Rule 13d-1(d)
| * | The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| CUSIP No. 24477E103 | SCHEDULE 13G |
| 1 |
Names of Reporting Persons
Jason Ronald Krantz | |||||
| 2 | Check the Appropriate Box if a Member of a Group (a) ☐ (b) ☐
| |||||
| 3 | SEC Use Only
| |||||
| 4 | Citizenship or Place of Organization
United States | |||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
5 | Sole Voting Power
20,657,840 (1) | ||||
| 6 | Shared Voting Power
0 | |||||
| 7 | Sole Dispositive Power
20,657,840 (1) | |||||
| 8 | Shared Dispositive Power
0 | |||||
| 9 |
Aggregate Amount Beneficially Owned by Each Reporting Person
20,657,840 (1) | |||||
| 10 | Check if the Aggregate Amount in Row (9) Excludes Certain Shares
☐ | |||||
| 11 | Percent of Class Represented by Amount in Row (9)
17.55% (2) | |||||
| 12 | Type of Reporting Person
IN | |||||
| (1) | Consists of (i) 206,813 shares of Class A Common Stock, par value $0.001 per share (“Class A Common Stock”) of Definitive Healthcare Corp. (the “Issuer”) that are issuable, at the Reporting Person’s election, upon exchange of an equal number of Limited Liability Company Units of AIDH Topco, LLC (“LLC Units”) held directly by the Reporting Person that are currently vested or that vest within 60 days, and (ii) 20,451,027 shares of Class A Common Stock of the Issuer that are issuable, at the holder’s election, upon exchange of an equal number of LLC Units held by DH Holdings (fka Jason R. Krantz 2009 Trust), of which the Reporting Person is the trustee and beneficiary, that are currently vested or that vest within 60 days. |
| (2) | Based on 117,687,935 outstanding shares of Class A Common Stock of the Issuer consisting of: (i) 97,030,095 shares of Class A Common Stock outstanding as of November 22, 2021 after giving effect to the offering completed on that date, as reported in the prospectus filed with the U.S. Securities and Exchange Commission on November 17, 2021 pursuant to Rule 424(b) (the “Prospectus”) and (ii) 20,657,840 shares of Class A Common Stock issuable upon exchange of the Reporting Person’s directly and indirectly held vested LLC Units. |
2
| Item 1(a). | Name of Issuer: |
Definitive Healthcare Corp.
| Item 1(b). | Address of Issuer’s Principal Executive Offices: |
550 Cochituate Rd
Framingham, MA 01701
| Item 2(a). | Name of Person Filing: |
Jason Ronald Krantz
| Item 2(b). | Address of Principal Business Office or, if none, Residence: |
The principal business office of the Reporting Person is:
550 Cochituate Rd
Framingham, MA 01701
| Item 2(c). | Citizenship: |
United States of America
| Item 2(d). | Title of Class of Securities: |
Class A common stock, $0.001 par value per share
| Item 2(e). | CUSIP Number: |
24477E103
| Item 3. | Not applicable. |
| Item 4. | Ownership |
(a)-(c) The responses of the Reporting Person to Rows 5, 6, 7, 8, 9 and 11 in the cover page which relates to the beneficial ownership of the Class A Common Stock of the Issuer, as of December 31, 2021, are incorporated herein by reference.
As of December 31, 2021, the Reporting Person beneficially owned 20,657,840 shares of Class A Common Stock of the Issuer, issuable upon the Reporting Person’s election to exchange an equal number of LLC Units, which represents approximately 17.55% of the shares of Class A Common Stock outstanding. The percentage ownership is based on 117,687,935 outstanding shares of Class A Common Stock of the Issuer consisting of: (i) 97,030,095 shares of Class A Common Stock outstanding as of November 22, 2021 after giving effect to the offering completed on that date, as reported in the Prospectus and (ii) 20,657,840 shares of Class A Common Stock issuable upon exchange of the Reporting Person’s directly and indirectly held vested LLC Units.
3
| Item 5. | Ownership of Five Percent or Less of a Class |
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.
| Item 6. | Ownership of More Than Five Percent on Behalf of Another Person |
The responses of the Reporting Person to Items 2(a) and 4 are incorporated herein by reference.
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company |
Not applicable.
| Item 8. | Identification and Classification of Members of the Group |
Not applicable.
| Item 9. | Notice of Dissolution of Group |
Not applicable.
| Item 10. | Certification |
Not applicable.
4
Signature
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: February 11, 2022
| /s/ Jason Krantz |
| Jason Krantz |